Cited by 814Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchSleep and related disorders

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

Schenck, Carlos H., Boeve, Bradley F., Mahowald, Mark W.·2013·Sleep Medicine

Abstract

Objective To provide a 16-year update from the authors' 1996 report documenting a 38% conversion from idiopathic rapid eye movement sleep behavior disorder (iRBD) to a parkinsonian disorder at a mean interval of nearly 13 years after the onset of iRBD in a series of 29 males > or =50 years old.Methods The methods of evaluation, diagnosis and follow-up were previously described in the 1996 report. All patients had video-polysomnography (vPSG) confirmed RBD.Results 80.8% (21/26) of patients who were initially diagnosed with iRBD eventually developed parkinsonism/dementia (three of the original 29 patients were lost to follow-up). The distribution of diagnoses was as follows: n=13, Parkinson's disease (PD); n=3, dementia with Lewy bodies (DLB); n=1, dementia (unspecified; profound); n=2, multiple system atrophy (MSA); n=2, clinically diagnosed Alzheimer's Disease (AD) with autopsy-confirmed combined AD plus Lewy body disease pathology. Among the 21 iRBD "converters," the mean age (±SD) of iRBD onset was 57.7±7.7 years; mean age (±SD) of parkinsonism/dementia onset was 71.9±6.6 years; and mean interval (±SD) from iRBD onset to parkinsonism/dementia onset was 14.2±6.2 years (range: 5-29 years).Conclusion The vast majority of men > or =50 years old initially diagnosed with iRBD in this study eventually developed a parkinsonian disorder/dementia, often after a prolonged interval from onset of iRBD, with the mean interval being 14 years while the range extended to 29 years. Also, the specificity of iRBD converting to parkinsonism/dementia is striking. These findings carry important clinical and research implications in the convergent fields of sleep medicine, neurology, and neuroscience, and identify an optimal clinical group for conducting prospective research studies utilizing putative neuroprotective agents to delay the emergence of, or halt the progression to, parkinsonism and/or cognitive impairment as manifestations of either PD, DLB or MSA.

Integrity signals

Registry

Crossref · 10.1016/j.sleep.2012.10.009

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schenck, C. H., Boeve, B. F., & Mahowald, M. W.
Affiliations
  • University of Minnesota (US)
  • Mayo Clinic (US)
Corresponding author
Schenck, Carlos H.
Venue
Sleep Medicine
Publisher
Elsevier BV
Published
2013-08
Volume
14
Issue
8
Pages
744-748
ISSN
1389-9457 (ISSN-L)
OpenAlex
W2050113652
Cited by
814
References
46
Citations by year
2026: 39 · 2025: 54 · 2024: 44 · 2023: 44 · 2022: 57 · 2021: 67 · 2020: 70 · 2019: 68 · 2018: 84 · 2017: 85 · 2016: 58 · 2015: 73 · 2014: 43 · 2013: 26 · 2012: 2
FWCI
42.30
Type
journal article
Language
en
Open access
closed
Locations
  • Sleep Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
idiopathic rapid eye movement sleep behavior disorder, parkinsonism, dementia, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, Alzheimer's disease, Lewy body disease, older men, long-term follow-up, neurodegeneration
MeSH terms
Aged, Brain, Dementia, Follow-Up Studies, Humans, Male, Middle Aged, Video Recording, Polysomnography, Age of Onset, Disease Progression, Multiple System Atrophy, REM Sleep Behavior Disorder, Parkinsonian Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review